Skip to main content
Erschienen in: Fluids and Barriers of the CNS 1/2022

Open Access 01.12.2022 | Research

Transcriptional profiling of transport mechanisms and regulatory pathways in rat choroid plexus

verfasst von: Søren N. Andreassen, Trine L. Toft-Bertelsen, Jonathan H. Wardman, René Villadsen, Nanna MacAulay

Erschienen in: Fluids and Barriers of the CNS | Ausgabe 1/2022

Abstract

Background

Dysregulation of brain fluid homeostasis associates with brain pathologies in which fluid accumulation leads to elevated intracranial pressure. Surgical intervention remains standard care, since specific and efficient pharmacological treatment options are limited for pathologies with disturbed brain fluid homeostasis. Such lack of therapeutic targets originates, in part, from the incomplete map of the molecular mechanisms underlying cerebrospinal fluid (CSF) secretion by the choroid plexus.

Methods

The transcriptomic profile of rat choroid plexus was generated by RNA Sequencing (RNAseq) of whole tissue and epithelial cells captured by fluorescence-activated cell sorting (FACS), and compared to proximal tubules. The bioinformatic analysis comprised mapping to reference genome followed by filtering for type, location, and association with alias and protein function. The transporters and associated regulatory modules were arranged in discovery tables according to their transcriptional abundance and tied together in association network analysis.

Results

The transcriptomic profile of choroid plexus displays high similarity between sex and species (human, rat, and mouse) and lesser similarity to another high-capacity fluid-transporting epithelium, the proximal tubules. The discovery tables provide lists of transport mechanisms that could participate in CSF secretion and suggest regulatory candidates.

Conclusions

With quantification of the transport protein transcript abundance in choroid plexus and their potentially linked regulatory modules, we envision a molecular tool to devise rational hypotheses regarding future delineation of choroidal transport proteins involved in CSF secretion and their regulation. Our vision is to obtain future pharmaceutical targets towards modulation of CSF production in pathologies involving disturbed brain water dynamics.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12987-022-00335-x.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
aCSF
Artificial cerebrospinal fluid
ATP
Adenosine triphosphate
cAMP
Cyclic adenosine monophosphate
CCC
Cation Cl cotransporter
cGMP
Cyclic guanosine monophosphate
CSF
Cerebrospinal fluid
FACS
Fluorescence-activated cell sorting
FGF
Fibroblast growth factor
Genecards
Human gene database
GEO
Gene Expression Omnibus
GF
Growth factor
GO term
Gene Ontology term
GPCR
G protein-coupled receptor
HEPES
4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid
HGNC
Gene Nomenclature Committee
HUGO
Human Genome Organisation
ICP
Intracranial pressure
KEGG
Kyoto Encyclopedia of Genes and Genomes
NCBI
National Center for Biotechnology Information
PBS
Phosphate-buffered saline
PDE
Phosphodiesterase
RNAseq
RNA sequencing
RSEM
RNA-Seq by Expectation Maximization
RTK
Receptor tyrosine kinase
SLC
Solute carrier
STAR
Spliced Transcripts Alignment to a Reference
TPM
Transcripts per million
Uniprot
Universal protein resource

Introduction

The brain is bathed in cerebrospinal fluid (CSF) that occupies the ventricular system, the subarachnoid space, and the interstitial space between structures and cells in the brain. The CSF serves to create buoyancy for the brain, to protect it from mechanical insult, and as a route by which metabolites, nutrients, and hormones can disperse within the brain [1]. The CSF is produced at a rate of 500 ml per day in adult humans [2], and the majority of the CSF secretion takes place across the choroid plexus [3], which is a specialized secretory tissue located in each of the ventricles. The choroid plexus consists of a monolayer of tight junction-connected epithelial cells, which rest on highly vascularized stroma with connective tissue [4].
A range of cerebral pathologies, i.e. hydrocephalus, stroke and subarachnoid hemorrhage, associate with elevated intracranial pressure (ICP). If left untreated, the brain tissue and the vasculature within compress, further reducing blood flow to the affected areas. Elevated ICP can occur following brain fluid accumulation arising either by reduced drainage of CSF following an obstruction in the brain fluid exit pathways or by hypersecretion of CSF, the latter of which has been observed in conditions such as choroid plexus hyperplasia, choroid plexus papilloma, and in a rodent model of posthemorrhagic hydrocephalus [57]. Elevated ICP is routinely treated by insertion of a ventriculo-peritoneal shunt or by a craniectomy [8, 9]. Although these are life-saving procedures, they are highly invasive and associated with severe side effects. Targeted and efficient pharmaceutical treatment aimed at reducing CSF secretion, and thus balancing the brain fluid content, is a desired addition to the clinical toolbox. However, such pharmaceutical approaches have, so far, generally failed due to intolerable side effects or lack of efficiency [10, 11].
Although the existence and production of CSF have been acknowledged for more than a century, the molecular mechanisms underlying this fluid secretion remain unresolved. Some choroidal transport mechanisms have been implicated in the CSF secretion, but their quantitative contribution and the molecular mechanisms by which the fluid is transported from the vascular compartment to the brain ventricles await determination [2, 3, 12]. Importantly, a complete map of the choroidal transport proteins may reveal other fluid-secreting transport mechanisms that could serve as future choroid plexus-specific pharmaceutical targets aimed at reducing CSF secretion in pathological conditions that would benefit from such treatments.
Here we performed transcriptomic analysis of rat choroid plexus from male and female rats and created a searchable database on the obtained transcriptomic profiles. To reveal putative future pharmacological targets, transport mechanisms and regulatory pathways were identified, ranked according to expression levels, and tied together in association networks.

Materials and methods

Experimental rats

This study conformed to the European guidelines and ethical regulations for use of experimental animals. The study utilizes 9-week-old Sprague Dawley rats (Janvier Labs, France) of male and female sex. The rats were housed with 12:12 light cycle with access to water and food ad libitum in accordance with the guidelines of the Danish Veterinary and Food administration (Ministry of Environment and Food) and approved by the animal facility at the Faculty of Health and Medical Sciences, University of Copenhagen. The rats were anaesthetized with intraperitoneal injection of xylazine and ketamine (6 mg/ml and 60 mg/ml in sterile water, 0.17 ml per 100 g body weight (ScanVet, Fredensborg, Denmark)) prior to decapitation and tissue collection.

Isolation of choroid plexus and proximal tubules

Choroid plexus (from lateral and 4th ventricles) were isolated from five male and five female rats, pooled respectively and stored in RNAlater® (Sigma-Aldrich, St. Louis, Missouri, USA) at − 80 °C. Kidney tissue was collected from the male rats, minced, and subsequently digested for 25 min at 37 °C in a table shaker at 850 rpm in collagenase solution containing 1 mg/ml collagenase (type II, Gibco®, Grand Island, NY, USA) and 1 mg/ml pronase (Roche, Mannheim, Germany) in buffer solution containing (in mM): 140 NaCl, 0.4 KH2PO4, 1.6 K2HPO4, 1 MgSO4, 10 Na-acetate, 1 α-ketoglutarate, 1.3 Ca-gluconate, 5 glycin, in addition to 48 mg/l aprotinin (trypsin inhibitor, Sigma-Aldrich, St. Louis, Missouri, USA) and 25 mg/l DNase I (grade II, Roche, Mannheim, Germany), pH 7.56. In five-minute intervals, 1 ml of the solution containing the kidney tissue was transferred to an eppendorf tube containing 1 ml cold buffer solution with 0.5 mg/ml bovine serum albumin (Sigma-Aldrich, St. Louis, Missouri, USA) and replaced by 1 ml collagenase solution. Proximal tubules were manually collected under a microscope, centrifuged at 600×g for 5 min, and the pellet stored in RNAlater® at − 80 °C.

Fluorescence-activated cell sorting (FACS) of choroid plexus epithelial cells

Choroid plexus was isolated from 10 male rats, minced, and digested in collagenase (15 mg/ml collagenase (type II, Gibco®, Grand island, NY, USA) in artificial CSF (aCSF)-HEPES containing (in mM): 120 NaCl, 2.5 KCl, 3 CaCl2, 1.3 MgSO4, 1 NaH2PO4, 10 glucose, 17 Na-HEPES, pH 7.56 for 30 min at 37 °C in a table shaker at 800 rpm. The supernatant was removed after 5 min centrifugation (600×g) and the pelleted cells were resuspended in aCSF-HEPES. The cells were triturated 20 times with a 1000 µl pipette and filtered through a 70 μm filter (pluriStrainer, Mini 70 µm, PluriSelect, Leipzig, Germany), prior to incubation with an anti-NKCC1 antibody with an extracellular epitope (1:200 in aCSF-HEPES, #ANT-071, Alomone Labs™, Jerusalem, Israel) for 30 min at 4 °C. The cells were pelleted (600 × g, 5 min) and resuspended in secondary antibody (1:500 in aCSF-HEPES, Alexa Fluor® 647—A-21245, Invitrogen™, Carlsbad, California, USA), in which it was kept for 20 min at 4 °C prior to centrifugation (600×g, 5 min) and resuspension in cold aCSF-HEPES. Cells were analyzed and sorted on a FACSAria Fusion flow cytometer (BD Biosciences, Lyngby, Denmark).

Immunohistochemistry

15 μl FACS suspension was placed on poly-d-lysine-coated coverslips for 30 min at room temperature, after which excessive liquid was removed and the attached cells covered with 4% paraformaldehyde in PBS for 15 min at room temperature. Coverslips were washed 3 times with 0.02% tween-20 in PBS (PBST) and permeabilized with PBST for 10 min at room temperature. Cells were treated with a blocking solution (4% normal goat serum (NGS) in PBST) for 1 h at 4 °C prior to exposure to primary antibody against AQP1 (1:400, #AQP-001, Alomone Labs™, Jerusalem, Israel) at 4 °C O/N. Coverslips were washed with PBST and incubated with secondary antibody (1:700, A-11034, Alexa Fluor® 488, Invitrogen™, Carlsbad, California, USA) and Phalloidin (1:400, A22287, Alexa Fluor™ 647, Invitrogen™, Carlsbad, California, USA) for 2 h at room temperature. Cells were washed and mounted onto microscope glass slides with ProLong™ Gold Antifade Mountant with DAPI (P36935, Invitrogen™, Carlsbad, California, USA).

RNA extraction and sequencing

The RNA extraction and library preparation were performed by Novogene Company Limited, UK with NEB Next® Ultra™ RNA Library Prep Kit (NEB, USA) prior to their RNA sequencing (paired-end 150 bp, with 12 Gb output) on an Illumina NovaSeq 6000 (Illumina, USA).

Bioinformatics and computational analyses:

All program parameter settings for library building and mapping, together with all scripts for the gene annotation and analysis are available at https://​github.​com/​Sorennorge/​MacAulayLab-RNAseq2.
Although it remains unknown whether a certain transcript level cut-off represents physiological relevance, all analyses exclude genes transcribed at levels below a cut-off at 0.5 transcripts per million (TPM) [13]. Raw data are available at the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) database (accession number: GSE194236).

RNA sequencing analysis

The 150 base paired-end reads were mapped to reference genome (Rattus norvegicus Rnor_6.0 v.103) using Spliced Transcripts Alignment to a Reference (STAR) RNA-seq aligner (v. 2.7.2a) [14]. The mapped alignment by STAR was normalized to TPM with RSEM (RNA-Seq by Expectation Maximization v. 1.3.3) [15]. Gene information was gathered with mygene (v3.1.0) python library [1618], from which gene symbol, alias, and Gene Ontology (GO) terms [1921] were extracted. Mitochondrial genes (seqname: MT) were omitted from the reference genome prior to comparison of the kidney proximal tubule transcriptional profiles with that of the choroid plexus, since the greater abundance of these genes in the proximal tubule would skew the plasma membrane transporter expression comparison.

Cross-species comparison

The human choroid plexus transcriptome was obtained from GEO database (GSE137619, SRR10134643-SRR10134648) [2224] and the mouse choroid plexus transcriptome was obtained from GEO (GSE66312, SRR1819706-SRR18197014) [25]. All samples were quality controlled with fastqc [26] and trimmed with Trimmomatic [27] (Slidingwindow 4:20, minimum length of 35 bp). The human and mouse samples, together with rat sample 3 (male), were mapped to the human reference genome (Homo sapiens GRCh38 v.104), the mouse reference genome (Mus musculus GRCm39 v.104), and rat reference genome (Rattus norvegicus Rnor_6.0 v.103) with STAR (v. 2.7.2a). The reference genome for rat, mouse, and human for the cross-species analysis only contained  gene/transcripts of biotype ‘protein coding’. Mapped alignments were normalized to TPM with RSEM (v. 1.3.3.) and the mean from the samples for human and mouse, respectively, were used for further analysis. Transcribed genes sharing gene name between the compared species (or their orthologue, collected from ensemble.org via biomart martview) were included in the cross-species comparison.

Category section

Gene lists of transporters, pumps, water and ion channels, and G protein-coupled receptors (GPCR) were collected from the ‘target and family list’ from Guide to Pharmacology [2831]. Genes annotated as ‘transporters’ were employed to generate the list of membrane transporters and pumps whereas genes annotated as ‘voltage-gated ion channels’, ‘ligand-gated ion channels’, and ‘other ion channels’ were employed to generate the list of water and ion channels. To filter for plasma membrane proteins, the transporter and pump gene list was initially filtered to exclude the mitochondrial and vacuolar transport families SLC25, ATP5, and ATP6V, after which the transporter and channel lists were filtered based on associated GO terms; ‘integral component of plasma membrane’ or ‘plasma membrane’, but only included genes annotated as ‘integral component of membrane’ or ‘transmembrane’, but not annotated as ‘lysosome’, ‘endosome membrane’, ‘lysosomal’, ‘mitochondrion’, ‘mitochondrial’, ‘golgi apparatus’, ‘vacuolar’, or ‘endoplasmic’. Genes annotated as ‘GPCR’ were employed to generate the list containing GPCRs. Receptor tyrosine kinases (RTK) were gathered from Human Genome Organisation (HUGO) Gene Nomenclature Committee (HGNC) database [32], with the annotations ‘receptor tyrosine kinase’ including sub group ‘ephrin receptors’ and ‘ErbB family’. The list of kinases was obtained from the Kyoto Encyclopedia of Genes and Genomes (KEGG) database [3336]for entries of ‘EC 2.7.10.2’ (non-specific protein-tyrosine kinase), ‘EC 2.7.12’ (Dual-specificity kinases) with the two sub-categories, and ‘EC 2.7.11’ (Protein-serine/threonine kinases) with the 33 sub-categories. These three entries were collected with organism specific “rno” (Rattus norvegicus) filter. These kinases were filtered for protein kinases by GO terms: ‘protein kinase activity’, ‘protein serine/threonine kinase activity’, ‘protein serine kinase activity’, ‘protein threonine kinase activity’, ‘protein tyrosine kinase activity’, ‘map kinase activity’. Kinases involved solely with transcription or cell cycle modulation were subsequently excluded. Phosphatases were gathered from the KEGG database with entries EC 3.1.3 (Phosphoric Monoester Hydrolases) with 108 subcategories. The phosphatases were filtered for protein-interacting phosphatases by GO terms: ‘phosphoprotein phosphatase activity’, ‘protein serine/threonine phosphatase activity’, ‘protein serine phosphatase activity’, ‘protein threonine phosphatase activity’, and ‘protein tyrosine phosphatase activity’. Phosphodiesterases (PDE) were collected based on gene name starting with ‘PDE’. Cyclases were obtained from the KEGG database [3336] entry numbers ‘EC 4.6.1.1’ (adenylate cyclase) and ‘EC 4.6.1.2’ (guanylate cyclase).

Network analysis

The network analysis was generated from protein–protein association tables from the String-database [37, 38] as a plugin for Cytoscape (v. 3.8.2) [39]. Firstly, full interaction tables were generated through a full protein query of every protein in the lists of transporters and pumps, water and ion channels, GPCRs, RTKs, kinases, phosphatases, PDEs and cyclases. Secondly, the tables were filtered for interaction between the ‘transporters and pumps’ and all the regulatory genes (lists of GPCRs, RTKs, kinases, phosphatases, PDEs, and cyclases). All interactions between regulatory proteins were discarded. The same was done for ‘water and ion channels’. We only included protein–protein associations that were curated in a database or were demonstrated to interact experimentally. Thirdly, these interaction tables were loaded back into Cytoscape (v. 3.8.2) and modulated: Confidence score (from string-db) of 0.6–1 was used for genes from the list ‘transporter and pumps’ interactions and 0.7–1 was used for genes from the list ‘water and ion channels’.

Results

To characterize the choroid plexus ‘transportome’, we obtained the transcriptomic profile of choroid plexus from adult male and female Sprague–Dawley rats by performing RNAseq of the tissue. The data are organized in a searchable webserver-based database (https://​cprnaseq.​in.​ku.​dk/​) to allow search for genes of interest. The database encompasses the genes expressed in the choroid plexus, their expression level in TPM, and their alias (protein name, to the extent that this feature was available).

The transcriptomic profile of rat choroid plexus mimics those of mouse and human

To determine the species similarity of the choroid plexus transcriptomic profile, we compared that obtained from the rat (Additional file 1, sheet 1) to published versions of these obtained from human [22] and murine [25] choroid plexus. Notably, this species comparison illustrates whether or not the gene is present but does not confer quantitative comparison of the expression levels. The rat shares 89% of its choroidal protein-coding genes with that of the human choroid plexus, and 91% with that of mice (Fig. 1). These numbers may represent an underestimate, as some of the remaining genes might not be annotated with the shared name or as an orthologue, or may fall just above or below the cut-off level of 0.5 TPM. However, the 11% non-shared expressed genes in humans only account for 3.3% of the total transcripts and only 5.5% of these non-shared genes were annotated with ‘transport activity’, meaning that only 0.1% are transporters not shared with the rat. The 9% non-shared expressed genes for mouse account for 2.8% of the total transcripts, and only 0.1% was annotated as transporters. Such transcriptomic similarity suggests that the functional integrity is conserved among these organisms, and that the rat is an applicable animal model in which to determine physiological aspects, especially those that are membrane transport-related, of the choroid plexus.

Transport proteins highly expressed in choroid plexus may be involved in CSF secretion

To obtain a complete list of transport proteins expressed in the choroid plexus and their transcriptomic abundance, the RNAseq data were filtered for genes encoding transport proteins located in the plasma membrane (see Methods). Each gene was associated with its alias, and a description of the type of membrane transport protein. Some protein names and their function were well established, while other transport mechanisms expressed in choroid plexus appeared not fully characterized with no general agreement on a given alias or function. The lists were therefore manually curated according to the Universal Protein Resource (Uniprot) [40] and the Human Gene Database (Genecards) [41] to ensure that the widest accepted alias and function were associated with each gene name. The transport proteins are divided into (i) coupled transporters and ATP-driven pumps and (ii) water and ion channels, and sorted according to their transcript abundance (Additional file 1, sheets 2 and 3). Tables 1 and 2 illustrate the 20 highest expressers in each category. Several of the transport proteins implicated in CSF secretion are found amongst these highly expressed transport proteins; different subunits of the Na+/K+-ATPase, the Na+,K+,2Cl cotransporter (NKCC1), aquaporin 1 (AQP1), and the HCO3 transporters NBCe2, NCBE, and AE2 [12, 42]. In addition, the lists present some additional transport proteins that could be envisaged to partake in CSF secretion, i.e. cation, anion and sulfate transporters (BOCT, BSAT1, SNAT1, SUT1, and MCT8, Table 1) in addition to various K+ and Cl ion channels (Table 2) with no prior association to CSF secretion. With such high relative expression in this tissue, these transport proteins are likely to serve a physiologically important function in choroid plexus, and could potentially be involved in CSF secretion.
Table 1
Highly transcribed transporters and pumps in choroid plexus
Gene
Alias
TPM
Description
Rank
FACS rank
Female rank
SLC22A17
BOCT
2396
Brain-specific organic cation transporter
1
1
1
ATP1B1
NKAβ
1553
Na+/K+-ATPase β1
2
2
2
FXYD1
FXYD1
1076
Na+/K+-ATPase γ1
3
3
3
SLC4A5
NBCE2
881
Na+,HCO3 cotransporter
4
7
4
SLC4A2
AE2
638
Cl/HCO3 exchanger
5
5
5
SLC13A4
SUT1
627
Na+,SO42− cotransporter
6
6
7
ATP1A1
NKA.α1
623
Na+/K+ ATPase α1
7
4
6
SLC31A1
CTR1
469
Cu2+ transporter 1
8
9
8
ATP2B3
PMCA3
396
Plasma membrane Ca2+ ATPase
9
15
11
SLC16A2
MCT8
380
Monocarboxylate transporter 8
10
13
9
SLC4A10
NCBE
325
Na+, HCO3 cotransporter
11
26
12
SLCO1C1
BSAT1
301
BBB-specific anion transporter 1
12
12
13
SLC38A3
SNAT3
298
Na+-coupled neutral amino acid transporter 3
13
8
10
SLC12A2
NKCC1
268
Na+, K+, 2Cl cotransporter
14
17
14
ATP1B2
NKA.β2
248
Na+/K+ ATPase β2
15
18
17
ATP11A
ATP11A
242
Phospholipid-transporting ATPase
16
23
19
ATP1B3
NKA.β3
236
Na+/K+ ATPase β3
17
10
15
TMEM30A
TMEM30A
229
P4-ATPase flippase β subunit
18
21
16
SLC12A4
KCC1
192
K+, Cl cotransporter
19
11
18
SLC20A2
PIT2
182
Na+-dependent PO43− transporter 2
20
16
21
RNAseq analysis revealing the 20 highest expressed genes encoding plasma membrane transporters and pumps in choroid plexus. TPM: transcripts per million; FACS rank: each gene’s rank in the FACS sample; Female rank: rank in the choroid plexus from female rats
Table 2
Highly transcribed membrane channels in choroid plexus
Gene
Alias
TPM
Description
Rank
FACS rank
Female rank
KCNJ13
Kir7.1
1372
Inwardly rectifying K+ channel 7.1
1
2
1
AQP1
AQP1
721
Aquaporin 1
2
1
2
KCNK1
TWIK-1
158
Two pore domain K+ channel
3
3
3
TRPM3
TRPM3
137
Transient receptor potential melastatin channel 3
4
7
4
TRPV4
TRPV4
92
Transient receptor potential vanilloid channel 4
5
4
5
ORAI1
ORAI1
62
Ca2+ release-activated Ca2+ modulator 1
6
5
6
MCOLN1
TRPML1
37
Transient receptor potential mucolipin channel 1
7
6
7
CLCN3
ClC-3
34
Voltage-gated Cl channel 3
8
15
9
KCNJ14
Kir2.4
31
Inwardly rectifying K+ channel 2.4
9
55
8
TRPM7
TRPM7
30
Transient receptor potential melastatin channel 7
10
18
12
KCNQ1
KV7.1
30
Voltage-gated K+ channel Kv7.1
11
9
10
P2RX6
P2X6
26
Purinergic Receptor X6
12
8
11
PKD2
TRPP2
25
Transient receptor potential polycystin channel 2
13
13
13
KCNA1
KV1.1
18
Voltage-gated K+ channel Kv1.1
14
43
20
ORAI3
ORAI3
17
Ca2+ release-activated Ca2+ modulator 3
15
10
14
KCNS1
KV9.1
16
Delayed rectifier voltage-gated K+ channel Kv9.1
16
11
15
KCNC3
KV3.3
15
Voltage-gated K+ channel Kv3.3
17
21
18
CLCN4
ClC-4
14
Voltage-gated Cl channel 4
18
23
19
GRIK5
GluK5
13
Kainate glutamate receptor 5
19
12
16
GJB2
Cx26
12
Connexin26
20
14
22
RNAseq analysis revealing the 20 highest expressed genes encoding plasma membrane channels in choroid plexus. TPM; transcripts per million, FACS rank; each gene’s rank in the FACS sample, Female rank; rank in the choroid plexus from female rats

The transcriptome of a pure fraction of choroid plexus epithelial cells is comparable to that of choroid plexus

The choroid plexus is a feather-like structure containing a monolayer of epithelial cells with centrally located vasculature, stroma, and immune cells. Most RNAseq studies of this tissue take advantage of the fact that the majority of the cells in the tissue are choroid plexus epithelial cells [43, 44] and thus include the entire structure into the RNAseq procedure [4549]. In this manner, some of the transcripts are anticipated to arise from other cell types than that of the choroid plexus epithelium. To resolve a putative discrepancy between a pure fraction of choroid plexus epithelial cells and that of the entire tissue, dissociated cells from acutely isolated choroid plexus were captured by FACS. In the choroid plexus, NKCC1 appears to be expressed exclusively on the luminal side of the epithelial cells [5052] and FACS with the anti-NKCC1 antibody targeted to an extracellular epitope on   this choroidal transport protein produced a fraction of highly fluorescent and large cells (Fig. 2A), which was absent in the FACS conducted in the absence of antibody (Fig. 2B) or with only the secondary antibody (Fig. 2C). Intact choroid plexus epithelial cells captured by FACS expressed AQP1 (Fig. 2D), which in the choroid plexus is expressed solely in the epithelial cells [53], demonstrating the epithelial origin of the captured cells. RNAseq analysis of the epithelial cells captured by FACS retrieved 97% of the genes detected in the entire choroid plexus structure (Fig. 2E). The 3% of the genes that were absent from the choroid plexus epithelial cells captured by FACS, were largely (> 95% of the genes with cell type annotation) annotated primarily to cell types other than epithelial cells [54, 55], such as cells of mesenchymal, endothelial, neuronal, immune, or glial origin, which reside in the choroid plexus structure [43]. The cell population obtained from the FACS procedure thus essentially represents choroid plexus epithelial cells. Choroid plexus epithelial cells captured by FACS displayed nearly identical transcriptomic profiles to that of the entire choroid plexus of choroidal transport proteins (97%, Fig. 2F) and channels (92%, Fig. 2G). The non-shared genes place around the cut-off TPM of 0.5 for both transporters and channels. More specifically, the transporters/pumps found amongst the top 20 highest expressers in the choroid plexus were all detected within the top 26 highest expressed transport proteins in the pure fraction of choroid plexus epithelial cells (Table 1). Such similarity was reproduced for choroid plexus membrane channels (except for the two ion channels Kir2.4 and Kv1.1 that placed further down the list), Table 2. Complete lists of transporters and membrane channels detected in the purified choroid plexus epithelial cells are included as Additional file 1, sheets 4 and 5. We conclude that RNAseq analysis of the complete choroid plexus structure provides a representative quantitative identification of the membrane transport proteins expressed in the choroid plexus epithelial cells.

The choroid plexus expresses a wide range of membrane transporters

The solute carriers (SLC) represent a large group of membrane transport proteins containing more than 400 members divided amongst 66 families [56]. The 66 family names and transport functions were collected from the Bioparadigms SLC database [57, 58]. Of the 66 existing SLC families, transcripts of 52 of these gene families were detected in choroid plexus, and 44 of these coding for SLC family members residing in the plasma membrane (representing 63% of all choroid plexus transporter and pump transcripts in the plasma membrane). To obtain an overview of choroidal plasma membrane transport functions, the 44 SLC families detected in the choroid plexus plasma membrane were grouped into 11 supercategories according to similarities in transported substrates (Fig. 3, Additional file 1, sheet 6). The most abundantly expressed supercategory consisted of 31 electrolyte and bicarbonate transporters (six families, 2602 TPM) followed by seven organic an/cationic transporters (one family, 2581 TPM) and 19 large anion transporters (five families, 1929 TPM). These are followed by amino acid and neurotransmitter transporters (36 genes), various sugar transporters (17 genes), and vitamin transporters (6 genes), (Fig. 3 and Additional file 1, sheet 6). Notably, the choroid plexus expresses a wealth of metal transporters (dispersed among 22 genes from five families, 928 TPM, with zinc transporters as the most prominent (15 genes)), (Fig. 3 and Additional file 1, sheet 6). With such abundance and variety in transporter types, the choroid plexus obviously serves important physiological roles in transporting solutes across this epithelial layer, besides that serving as the CSF secreting machinery.

Female and male rats share choroid plexus transcriptomic profile

To verify the sex-specific transcriptomic profile of female versus male rat choroid plexus, we compared the expression profiles for choroid plexus obtained from each age-matched sex. The female choroid plexus shared 98% of the overall expression profile with the male choroid plexus (Fig. 4A), suggesting high functional similarity of the choroid plexus in the two sexes. Notably, the non-shared genes account for less than 0.1% of the total transcripts. To reveal potential sex-specific differences within the CSF secreting machinery, we compared the expression profile for membrane transport mechanisms. Choroid plexus obtained from the female rats shared 98% of the transcripts encoding transporters (Fig. 4B) and 95% of those encoding channels (Fig. 4C) with the male rat. The male 20 highest expressed genes were included in the top 21 highest expressed transporter genes in the female transporter category (Table 1) and in the top 22 highest expressed channel genes in the female channel category (Table 2). Choroid plexus obtained from the two sexes thus shares high degree of expression profile similarity, with near-identical expression of abundant transport proteins. These data suggest a comparable choroid plexus CSF secreting machinery in female and male rats.

The choroid plexus transcriptome differs from that of another high-capacity isotonic fluid-transporting epithelium

To reveal possible transport protein candidates involved in fluid secretion across the choroid plexus, we obtained the transcriptomic profile of an epithelium of comparable isotonic fluid-transporting capacity to that of choroid plexus; the kidney proximal tubule [2]. The majority (91%) of the transcribed genes obtained in the proximal tubule were detected in the choroid plexus. However with the larger number of transcribed genes found in the choroid plexus, this common pool of transcribed genes amounted to only 41% of the choroidal expression profile (Fig. 5A). 64% of the transporter-encoding transcribed genes obtained from the proximal tubule were retrieved in the choroidal samples (in which proximal tubule transcribed genes represented 30%, Fig. 5B). In the channel category, the equivalent numbers were 52% of the proximal tubule transcribed genes being retrieved in the choroid plexus samples and 15% of the choroidal transcribed genes detected in the proximal tubule (Fig. 5C). Of the 20 highest expressed transporters/pumps (Table 3) and channels (Table 4) in the proximal tubule (see Additional file 1, sheets 7 and 8 for the complete lists), only 10 (transporters and pumps) and 10 (water and ion channels) genes were found in the choroid plexus (Tables 3 and 4). The Na+/K+-ATPase α1β1, AQP1, TRP channels, and some voltage-gated Cl channels present themselves as common transport mechanisms in the two tissues. Although the proximal tubule joins the choroid plexus in the ranks of high-capacity fluid-transporting epithelia, the molecular machinery driving the fluid secretion appears, at least in part, to rely on distinct transport mechanisms.
Table 3
Highly transcribed transporters and pumps in proximal tubule
Gene
Alias
TPM
Description
PT Rank
CP Rank
SLC7A13
XAT2
7344
Na+-independent aspartate/glutamate transporter
1
N/A
SLC3A1
NBAT
3113
Neutral and basic amino acid transporter
2
98
SLC16A4
MCT5
993
Monocarboxylate transporter 5
3
N/A
SLC13A1
NAS1
384
Na+, SO42− transporter 1
4
N/A
FXYD2
FXYD2
359
Na+/K+ ATPase γ2
5
N/A
PDZD11
PDZD11
279
Plasma membrane Ca2+ ATPase-interacting single-PDZ Protein
6
30
ABCG2
BCRP
164
ATP binding cassette transporter G2
7
209
SLC17A3
NPT4
148
Na+, PO43− transporter 4
8
N/A
SLC5A12
SMCT2
147
Na+-coupled monocarboxylate transporter 2
9
N/A
SLC31A1
CTR1
136
Cu2+ transporter 1
10
8
SLC51B
OSTB
131
Organic solute transporter β
11
N/A
ATP1B1
NKA.β1
98
Na+/K+-ATPase β1
12
2
MAGT1
MAGT1
72
Mg2+ transporter protein 1
13
58
SLC34A1
NPT2
67
Na+, PO43− transporter 2
14
N/A
SLC16A12
MCT12
45
Monocarboxylate transporter 12
15
42
SLC22A6
OAT1
29
Organic anion transporter 1
16
N/A
SLC22A2
OCT2
25
Organic cation transporter 2
17
N/A
TMEM30A
TMEM30A
24
P4-ATPase flippase β subunit
18
18
SLC15A2
PEPT2
22
Peptide transporter 2
19
87
SLC5A2
SGLT2
22
Na+, glucose cotransporter 2
20
137
RNAseq analysis revealing the 20 highest expressed genes encoding plasma membrane transporters and pumps in proximal tubule. TPM: transcripts per million; PT rank: each gene’s rank in the proximal tubule sample; CP rank: each gene’s rank in the choroid plexus sample; N/A: not applicable if the genes is transcribed below the applied cut-off of 0.5 TPM
Table 4
Highly transcribed membrane channels in proximal tubule
Gene
Alias
TPM
Description
PT rank
CP rank
KCNJ16
Kir5.1
235
Inwardly rectifying K+ channel 5.1
1
N/A
KCNJ1
Kir1.1
89
Inwardly rectifying K+ channel 1.1
2
N/A
AQP1
AQP1
48
Aquaporin 1
3
2
TRPV1
TRPV1
15
Transient receptor potential vanilloid channel 1
4
N/A
GJB2
Cx26
13
Connexin 26
5
20
AQP3
AQP3
10
Aquaporin 3
6
N/A
AQP7
AQP7
9
Aquaporin 7
7
N/A
TRPM7
TRPM7
9
Transient receptor potential melastatin channel 7
8
10
GABRP
GABARπ
9
GABA(A) receptor π
9
N/A
MCOLN1
TRPML1
8
Transient receptor potential mucolipin channel 1
10
7
MCOLN3
TRPML3
7
Transient receptor potential mucolipin channel 3
11
N/A
CLCN4
ClC-4
4
Voltage-gated Cl channel 4
12
18
CFTR
CFTR
4
Cystic fibrosis transmembrane conductance regulator
13
N/A
CLCNKA
ClCK1
3
Voltage-gated Cl channel
14
N/A
GJB1
Cx32
3
Connexin 32
15
N/A
KCNJ15
Kir4.2
2
Inwardly rectifying K+ channel 4.2
16
85
CHRNB1
ACHB
2
Acetylcholine receptor β
17
47
PANX2
Panx2
2
Pannexin 2
18
40
P2RX4
P2X4
2
Purinergic receptor X4
19
28
GJA1
Cx43
2
Connexin 43
20
27
RNAseq analysis revealing the 20 highest expressed genes encoding plasma membrane channels in proximal tubule. TPM: transcripts per million; PT rank: each gene’s rank in the proximal tubule sample; CP rank: each gene’s rank in the choroid plexus sample, N/A: not applicable if the genes is transcribed below the applied cut-off of 0.5 TPM

Receptors and intracellular modulators may be involved in regulation of CSF secretion

It is anticipated that CSF secretion is tightly regulated to ensure stable brain fluid dynamics and thus intracranial pressure, although the regulatory control of CSF secretion is largely unresolved. To reveal which plasma membrane receptors are expressed in choroid plexus, all G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs) expressed in choroid plexus were filtered from the RNAseq data set and listed according to their expression levels (Additional file 1, sheets 9 and 10). Each gene was associated with its alias and a description of the type of receptor (if known). All receptors were manually curated [40, 41] to ensure that the widest accepted alias and function were associated with each gene name. Of the 20 highest expressed GPCRs (Table 5), the serotonin receptor 2C (HTR2C) figures at the top, and is accompanied by the endothelin receptor type B, the GABAB receptor, corticotrophin releasing hormone receptor 2, several adhesion-associated receptors, and those belonging to the family of frizzled GPRCRs. Notably, the list contains several orphan GPCRs (GPR146, GPR175, GPR107) without well-established ligands and functions, although GPR146 has been proposed as a receptor for insulin C-peptide [59], which in turn may regulate the Na+/K-ATPase [60]. Dominant amongst the receptor tyrosine kinase top expressers (Table 5) are receptors for growth factors (GF) of various kinds; fibroblast GF, platelet derived GF, vascular endothelial GF, and insulin/insulin-like receptors, in addition to various immune-related RTKs.
Table 5
Highly transcribed plasma membrane receptors in choroid plexus
Gene
Alias
TPM
Description
G protein-coupled receptors
HTR2C
5-HT2C
677
Serotonin receptor 2C
EDNRB
ETB
150
Endothelin receptor type B
ACKR3
ACKR3
78
Atypical chemokine receptor 3
FZD2
FZ-2
76
Frizzled-2
SMO
FZ-11
62
Frizzled-11
GPR146
GPR146
51
G protein-coupled receptor 146
ADGRG1
GPR56
49
Adhesion G protein-coupled receptor G1
TPRA1
GPR175
42
G protein-coupled receptor 175
FZD7
FZ-7
36
Frizzled-7
GABBR1
GABABR1
32
GABA(B) receptor 1
CRHR2
CRHR2
28
Corticotrophin releasing hormone receptor 2
GPRC5C
GPRC5C
27
G protein-coupled receptor C5C
GPR107
GPR107
23
G Protein-Coupled Receptor 107
ADGRA3
ADGRA3
21
Adhesion G protein-coupled receptor A3
GPR137
GPR137
20
G protein-coupled receptor 137
FZD6
FZ-6
18
Frizzled-6
ADGRL1
ADGRL1
16
Adhesion G protein-coupled receptor L1
LGR4
GPR48
13
G protein-coupled receptor 48
ADGRF5
ADGRF5
12
Adhesion G protein-coupled receptor F5
GPR162
GPR162
12
G protein-coupled receptor 162
Receptor tyrosine kinases
FGFR2
FGFR-2
181
Fibroblast growth factor receptor 2
FGFR1
FGFR-1
110
Fibroblast growth factor receptor 1
PDGFRA
PDGFRα
83
Platelet derived growth factor receptor α
NTRK2
NTRK2
75
Neurotrophic receptor tyrosine kinase 2
DDR1
DDR1
54
Discoidin domain receptor tyrosine kinase 1
TYRO3
TYRO3
48
TYRO3 protein tyrosine kinase
RYK
RYK
38
Receptor like tyrosine kinase
KDR
VEGFR2
25
Vascular endothelial growth factor receptor 2
INSR
INSR
24
Insulin receptor
PTK7
PTK7
22
Protein tyrosine kinase 7
PDGFRB
PDGFRβ
20
Platelet derived growth factor receptor β
LMTK2
LMTK2
17
Lemur tyrosine kinase 2
CSF1R
CSF1R
17
Colony-stimulating factor 1 receptor
TIE1
TIE1
16
Tyrosine kinase with immunoglobin- and EGF like domains 1
EPHB4
EPHB4
16
Ephrin receptor B4
FLT1
VEGFR1
15
Vascular endothelial growth factor receptor 1
AXL
AXL
12
AXL receptor tyrosine kinase
FGFR3
FGFR-3
12
Fibroblast growth factor receptor 3
IGF1R
IGF1R
10
Insulin-like growth factor 1 receptor
TEK
TIE2
9
Tyrosine kinase with immunoglobin- and EGF like domains 2
RNAseq analysis revealing the 20 highest expressed genes encoding plasma membrane GPCRs (top) and receptor tyrosin kinases (bottom) in choroid plexus. TPM; transcripts per million
The receptors generally exert their function via intracellular signaling cascades promoting phosphorylation (kinases) or dephosphorylation (phosphatases) of target proteins such as transport proteins and transcriptional factors potentially promoting expression of select transport proteins. To reveal such regulatory proteins expressed in choroid plexus, the RNAseq data were filtered for kinases and phosphatases, and the data manually curated to obtain alias and function (complete lists found as Additional file 1, sheets 11 and 12). The list of the 20 highest expressed kinases (Table 6) encompasses a large variety of kinases including MAP kinases, AKT kinases, and casein kinases. Interestingly, the Stk39 kinase (SPAK), which is the second highest expressed kinase in choroid plexus, is directly implicated in CSF secretion via its ability to activate NKCC1 [6]. The list of the 20 highly expressed phosphatases covers a variety of phosphatases encompassing both serine/threonine and tyrosine phosphatases (Table 6).
Table 6
Highly transcribed kinases and phosphatases in choroid plexus
Gene
Alias
TPM
Description
Kinases
MAPK4
MAPK4
324
Mitogen-activated protein kinase 4
STK39
SPAK
320
STE20/SPS1-related proline-alanine-rich protein kinase
PINK1
PINK1
196
PTEN induced kinase 1
SGK1
SGK1
134
Serum/glucocorticoid-regulated kinase 1
CSNK1A1
CK1α1
131
Casein kinase 1, α1
MAP2K2
MAPKK2
123
Mitogen-activated protein kinase kinase 2
AKT1
AKT1
121
AKT serine/threonine kinase 1
CSNK2A1
CK2α1
121
Casein kinase 2, α1
CSNK1G2
CK1 γ 2
109
Casein kinase 1, γ2
TGFBR2
TGFBR2
102
Transforming growth factor β receptor 2
MAPK1
MAPK1
92
Mitogen-activated protein kinase 1
DMPK
DM1PK
90
DM1 protein kinase
BCKDK
BCKDK
87
Branched chain ketoacid dehydrogenase kinase
MAPK3
MAPK3
86
Mitogen-activated protein kinase 3
MAPKAPK2
MAPKAP2
75
MAP kinase-activated protein kinase 2
HIPK1
HIPK1
75
Homeodomain-interacting protein kinase 1
PDK3
PDK3
74
Pyruvate dehydrogenase kinase 3
GSK3A
GSK3A
68
Glycogen synthase kinase 3α
SGK3
SGK3
66
Serum/glucocorticoid-regulated kinase 3
MAP2K1
MAPKK1
65
Mitogen-activated protein kinase kinase 1
Phosphatases
PPP2CB
PP2B
268
Protein phosphatase 2 Cβ
PTP4A2
PTP4A2
179
Protein tyrosine phosphatase 4A2
PPP1CA
PP1A
136
Protein phosphatase 1 Cα
PPP5C
PP5
118
Protein phosphatase 5 C
PPP1CC
PP1C
105
Protein phosphatase 1 Cγ
CTDSP1
CTDSP1
102
CTD small phosphatase 1
PTPRA
PTPRA
98
Protein tyrosine phosphatase receptor α
PPP1CB
PP1B
86
Protein phosphatase 1 Cβ
PPP2CA
PP2A
85
protein phosphatase 2 Cα
CTDNEP1
CTDNEP1
63
CTD nuclear envelope phosphatase 1
PTPN11
PTPN11
57
Protein tyrosine phosphatase non-receptor 11
MTMR2
MTMR2
55
Myotubularin related protein 2
PPM1F
PPM1F
54
Protein phosphatase, Mg2+/Mn2+ dependent, 1F
DUSP14
DUSP14
51
Dual specificity protein phosphatase 14
PPM1G
PPM1G
48
Protein phosphatase, Mg2+/Mn2+ dependent, 1G
PGP
PGP
47
Phosphoglycolate phosphatase
MTMR6
MTMR6
44
Myotubularin related protein 6
PTP4A1
PTP4A1
43
Protein tyrosine phosphatase 4A1
PPP6C
PP6
41
Protein phosphatase 6 C
PPP4C
PP4
40
Protein phosphatase 4 C
RNAseq analysis revealing the 20 highest expressed genes encoding protein kinases (top) and phosphatases (bottom) in choroid plexus. TPM: transcripts per million
Some kinases are activated by cyclic nucleotides, such as cAMP required for PKA activation and cGMP required for PKG activation. The abundance of these cyclic nucleotides is regulated by cyclases and phosphodiesterases, the presence and activity of which could well modulate the CSF secretion in the choroid plexus [6163]. The RNAseq data set was therefore filtered for the presence of these, and the 10 highest expressers amongst cyclases and phosphodiesterases are listed in Table 7, with the complete lists of manually curated (for alias and function) genes included as Additional file 1, sheets 13 and 14.
Table 7
Highly transcribed phosphodiesterases and cyclases choroid plexus
Gene
Alias
TPM
Description
Phosphodiesterases
PDE6D
PDE6D
45
Phosphodiesterase 6D
PDE9A
PDE9A
21
Phosphodiesterase 9A
PDE6G
PDE6G
15
Phosphodiesterase 6G
PDE5A
PDE5A
15
Phosphodiesterase 5A
PDE4DIP
Myomegalin
15
Phosphodiesterase 4D interacting protein
PDE12
PDE12
7
Phosphodiesterase 12
PDE7A
PDE7A
3
Phosphodiesterase 7A
PDE8A
PDE8A
3
Phosphodiesterase 8A
PDE1B
PDE1B
3
Phosphodiesterase 1B
PDE1A
PDE1A
3
Phosphodiesterase 1A
Cyclases
ADCY6
AC6
51
Adenylate cyclase 6
NPR2
ANPR-B
20
Atrial natriuretic peptide receptor 2
ADCY9
AC9
10
Adenylate cyclase 9
GUCY1B1
GUCY1B1
7
Guanylate cyclase 1, soluble β1
NPR1
ANPR-A
6
Atrial natriuretic peptide receptor 1
GUCY1A1
GUCY1A1
6
Guanylate cyclase 1, soluble α1
ADCY5
AC5
3
Adenylate cyclase 5
GUCY1A2
GUC1A2
2
Guanylate cyclase 1, soluble α2
ADCY4
AC4
2
Adenylate cyclase 4
ADCY3
AC3
2
Adenylate cyclase 3
RNAseq analysis revealing the 10 highest expressed genes encoding phosphodiesterases (PDE, top) and cyclases (bottom) in choroid plexus. TPM: transcripts per million

Network analysis of choroid plexus

To obtain insight into potential physiologically relevant regulatory properties of the choroid plexus transport machinery, we built association networks of transporters/pumps (Fig. 6) and channels (Fig. 7) with the various choroidal receptors (GPCRs and RTKs) and intracellular messengers (kinases, phosphatases, PDEs, and cyclases). Such networks are obtained with a string database and provide links between the transport mechanisms and a regulatory factor, if such has been implied experimentally or in curated databases [64] in published work on any cell type or tissue. Most notably, various isoforms of protein kinase A (PKA) and MAP kinases (MAPK) associate with phosphorylation of different subunits of the Na+/K+-ATPase and the plasma membrane Ca2+-ATPase (PMCA), whereas the facilitative glucose transporter (GLUT4) and the Na+/H+ exchanger (NHE1) associate with a variety of different regulatory candidates (Fig. 6). The SPAK-mediated regulation of NKCC1 in choroid plexus [6, 65] is evidenced in the network association of these proteins along with the with-no-lysine kinases (WNK1-4), oxidative stress responsive kinase 1 (OSR1), and other cation-Cl cotransporters (Fig. 6). The different PKA isoforms associate with various ion channels as well, most prominently with voltage-gated K+ channels, while PKC isoforms associate with the transient receptor potential vanilloid channel 4 (TRPV4) (Fig. 7), which modulates the rate of CSF secretion [66] and has been implicated in hydrocephalus development in a rat model of genetically-induced hydrocephalus [67]. In addition, various highly expressed phosphatases associate with different ligand- and voltage-gated ion channels (Fig. 7). Altogether, such network analysis indicated a plethora of potential regulatory pathways, some of which could be implicated in regulation of CSF secretion, or other physiological processes.

Discussion

Here we reveal the choroid plexus abundance of transcripts encoding plasma membrane transport mechanisms that could potentially be involved in CSF secretion as well as those encoding regulatory factors that could partake in regulation of the CSF secretion machinery. The transcriptomic profile of male and female rat choroid plexus was nearly identical [68], as was the case for their transportome. The rat choroid plexus transcriptomic profile displayed high (~ 90%) similarity to that of human and mice. The similarity may be even been higher than here reported, due to limited gene information of some of the retrieved genes.
Despite the fact that the existence of CSF and its continuous secretion from the blood to the brain have been long acknowledged, the exact molecular mechanisms by which this secretory process occurs have remained elusive [2, 12]. Several plasma membrane transport proteins are suggested to be implicated in the process, but their individual quantitative contribution remains unresolved. Several of these were detected amongst the 20 highest expressed membrane transport mechanisms revealed by filtering and curation of the RNAseq data obtained from rat choroid plexus; The Na+/K+-ATPase α1β1, NKCC1, TRPV4, AQP1, and the HCO3 transporters NBCe2, NCBE, and AE2 [12, 42]. The transporter ranking was near-identical in RNAseq of entire choroid plexus and in choroid plexus epithelial cells captured by FACS, in support of the choroid plexus consisting predominantly of cells of epithelial origin [43]. These ranked lists of choroid plexus transport mechanisms, in addition, provided gene names of other highly expressed transport proteins, which could potentially contribute to CSF secretion, but may never have been investigated for such a function. Of interest could be the highly expressed cation and anion transporters (BOCT, BSAT1), both of which are detected in brain barrier tissues [69, 70]. BOCT is expressed widely across many brain cell types, whereas the BSAT1 is expressed predominantly in choroid plexus and other barrier cell types, i.e. endothelial cells and pericytes [71]. The transported substrate of the former remains elusive [69], whereas the latter is involved in the transport of thyroxine, for which the choroid plexus is renowned [70]. The Na+-coupled sulfate transporter (SUT-1), ranked as number 6 highest expressed amongst transporters and pumps, is virtually exclusively expressed in choroid plexus amongst brain cells [72] (with some expression in the vascular leptomeningeal cells [71]). MCT8 and SNAT3 are both highly expressed in choroid plexus epithelial cells, but also detected in other brain cell types, albeit the latter predominantly in barrier-related cells, such as vascular endothelial cells, pericytes and ependymal cells [71]. MCT8 is involved in thyroxine transport [73] while SNAT3 contributes to the high glutamine content of the CSF [74]. None of these has, as of yet, been investigated for a potential implication in CSF secretion.
Comparison of the choroid plexus transcriptomic profile to that of another isotonic fluid-transporting epithelium of similar capacity, the kidney proximal tubules [2], revealed that choroid plexus expressed more than double the number of genes (~ 13,500 genes) compared to the proximal tubules (~ 6000 genes, [75, 76]). 64% of the transport protein transcripts detected in the proximal tubules were also expressed in the choroid plexus, but these only amounted to 30% of those detected within this transcript category in the choroid plexus, supporting the notion that the choroid plexus serves a variety of tasks other than CSF secretion, some of which include transepithelial solute transport. Amongst the genes encoding transport proteins transcribed in both fluid-transporting epithelia, surprisingly few placed among highly expressed genes in both tissues: the Na+/K+-ATPase α1β1, AQP1, a voltage-gated Cl channel (ClC-4), in addition to two TRP channels (TRPML1 and TRPM7). Such similarity could suggest important roles of these particular transport proteins in the secretory processes (or regulation thereof) in these tissues [7780], although, clearly, each epithelium appears to employ additional tissue-specific transport pathways to provide the transepithelial fluid transport. Of interest, an isoform of the Na+-coupled glucose transporter (SGLT2; SLC5A2), which was previously annotated to sole expression in the proximal tubules [81], was here detected in the choroid plexus transcriptome, albeit at a lower relative expression level (6 TPM) than that observed in the proximal tubule sample (22 TPM). The choroidal transcript abundance of SGLT2 is confirmatory of its recently demonstrated protein expression in mouse and human choroid plexus [82, 83]. The proposed selective SGLT2 expression in the proximal tubules led to development of SGLT2 inhibitors as a selective treatment option for type 2 diabetes mellitus [84, 85]. Such approach may have to be reconsidered based on SGLT2 expression in choroid plexus (this study and [82, 83]), where the transport protein could potentially partake in CSF secretion, like its homologue, SGLT1, participates in fluid transport across the small intestine [86].
The families of solute carriers (the SLCs) were highly represented in the transportome of the choroid plexus (approximately 63% of all the plasma membrane transport and pump protein transcripts), with most of the existing families expressed in this tissue (52 out of 66). Choroid plexus SLC expression is developmentally regulated, with notable upregulation of amino acid transporter families during embryonic stages [45, 87]. Grouping these SLC families into super categories defined by their transported substrate, we demonstrate that the electrolyte/HCO3 and anion/cation transporters dominated at the transcript level. These were followed by amino acid, sugar, metal and vitamin transporters, in support of a role for choroid plexus in supplying the brain tissue with nutrients, micro-nutrients, and various co-factors [87, 88]. Notably, the choroid plexus is enriched in transcripts encoding metal transport proteins, with 22 genes dispersed among five different families of metal ion transporters. The choroidal expression of 15 different genes encoding various Zn2+ transporters of the efflux (SLC30; ZnT) and influx (SLC39, ZIP) types may serve to ensure transepithelial brain delivery of Zn2+ to various biochemical processes that are instrumental for proper brain development and function [87, 89, 90].
To reveal potential regulatory cascades involved in modulation of CSF secretion, we obtained lists of highly expressed plasma membrane receptors and signaling pathways expressed at the transcriptional level in choroid plexus. Amongst the GPCRs, the serotonin receptor of the 5-HT2C type was expressed at fourfold higher abundance that the second-highest expressed receptor. The 5-HT2C receptor is expressed on the luminal side of the choroid plexus epithelium [91] and its activation leads to Gq-dependent Ca2+ release from intracellular stores [92, 93], which subsequently promotes release of the insulin produced within the choroid plexus epithelium [93] and may modulate choroidal ion channel activity [94] and the rate of CSF secretion [95, 96]. The endothelin receptor B appears as the second highest expressed GPCRs, with subtype A further down the list, in support of their protein expression in the choroid plexus [97]. Endothelin may reduce the rate of CSF secretion [98], possibly in part via its action on the choroidal blood flow [99]. Of the receptor tyrosine kinases, growth factor receptors dominate the list of highest expressers, with three members of the family of fibroblast growth factor (FGF) receptors on the top 20 list (and two of these at the top). FGF receptors are detected at the protein level in choroid plexus [100] and FGFs may be implicated in brain fluid homeostasis by their ability to modulate NKCC1 activity [101] and to induce ventriculomegaly in a rodent model upon prolonged intraventricular infusion, at least in part due to formation of fibrosis and collagen deposits in the CSF drainage paths [102]. The latter observation aligns with the diminished foramen magnum area observed in hydrocephalic children bearing mutations in the gene encoding FGFR2 [103].
Lists of highly expressed intracellular signaling molecules include various cyclases, phosphodiesterases, kinases and phosphates. The vast majority of these remains to be associated with CSF secretion or regulation thereof, but may provide valuable hints to pursue in future efforts to modulate CSF secretion pharmacologically without targeting the choroidal transporters, many of which are expressed in other cell types or epithelia in the body. The cyclase-coupled receptors for atrial natriuretic peptide (ANPR-A and ANPR-B) were both detected amongst the top 10 highest expressed cyclases in the choroid plexus, and previously demonstrated at the protein level in this tissue [104]. ANP, via its induction of cGMP formation, may [104] or may not [105] cause decreased CSF secretion, and altered choroid plexus ANP receptor abundance in various forms of experimental hydrocephalus could indicate involvement in brain fluid dynamics [106]. Also of interest is the placement of the Ste20-related proline/alanine-rich kinase, SPAK, as the second highest expressed kinase in choroid plexus. SPAK is implicated in regulation of the CSF-secreting NKCC1 [6, 65, 66] and figures prominently in our network analysis as associated with NKCC1 as well as other cation, Cl cotransporters (CCCs). Other choroidal kinases and phosphatases associate with different transport mechanisms, e.g. various isoforms of the Na+/K+-ATPase and the TRPV4 channel, and may provide novel paths to investigate in future determinations of choroid plexus transport and its regulation.
As potential limitations to our study, we acknowledge the possibility that the lists of transporters, receptors, and intracellular signaling molecules are not absolute, as the information and annotation in the various databases, on which these are based, may be incomplete and with various levels of reliability. Accordingly, the volume activated anion channels of the LRRC8 family, which have been detected in rodent choroid plexus [107], were not included in the ion channel list from Gene Ontocology in the first filtration step (see Methods), and are therefore not included in the list of choroidal ion channels. The filtration based on GO term annotation and manual curation was performed based on the available information and to the best of our knowledge. The network analysis is based on published work. Therefore, novel and unexplored connections between different transporters and their potential regulatory pathways are anticipated to be revealed by future research efforts. Lastly, transcript abundance may vary among the different choroid plexuses [25] and may not mirror the quantitative expression at the protein level, some of which have previously been reported [108]. In addition, it remains unresolved whether transport proteins with lesser mRNA abundance, at the protein level may remain functionally represented and physiologically relevant (e.g. Kv1.3 with low transcript abundance (this study and [25]), but detected at the functional level in isolated rodent choroid plexus [94]). Nevertheless, in the current study, we have created discovery tables of the transport mechanisms and regulatory pathways of the rat choroid plexus, and linked them via network analysis. We demonstrated high similarity between species (human and mouse) and sexes. The discovery tables provide semi-quantitative ranked lists of transport mechanisms that could participate in CSF secretion and suggest regulatory candidate genes that could be involved in their regulation. With these lists, we envision that researchers in the field may devise hypotheses regarding future quantification of transport mechanisms and their regulation, with the vision to obtain rational pharmaceutical targets for CSF production modulation in the pathologies involving disturbed brain water dynamics.

Acknowledgements

We are grateful for the technical assistance from Trine Lind Devantier and Dagne Barbuskaite and for the valuable input on transcriptomics from Tune H Pers, Novo Nordic Center for Basic Metabolic Research, University of Copenhagen.

Declarations

Animal experiments were in compliance with the European Community Council Directive 2010/63/EU on the Protection of Animals used for Scientific Purposes.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anhänge
Literatur
1.
Zurück zum Zitat Redzic ZB, Preston JE, Duncan JA, Chodobski A, Szmydynger-Chodobska J. The choroid plexus-cerebrospinal fluid system: from development to aging. Curr Top Dev Biol. 2005;71:1–52.PubMedCrossRef Redzic ZB, Preston JE, Duncan JA, Chodobski A, Szmydynger-Chodobska J. The choroid plexus-cerebrospinal fluid system: from development to aging. Curr Top Dev Biol. 2005;71:1–52.PubMedCrossRef
2.
Zurück zum Zitat Damkier HH, Brown PD, Praetorius J. Cerebrospinal fluid secretion by the choroid plexus. Physiol Rev. 2013;93(4):1847–92.PubMedCrossRef Damkier HH, Brown PD, Praetorius J. Cerebrospinal fluid secretion by the choroid plexus. Physiol Rev. 2013;93(4):1847–92.PubMedCrossRef
3.
Zurück zum Zitat Hladky SB, Barrand MA. Fluid and ion transfer across the blood-brain and blood-cerebrospinal fluid barriers; a comparative account of mechanisms and roles. Fluids Barriers CNS. 2016;13(1):19.PubMedPubMedCentralCrossRef Hladky SB, Barrand MA. Fluid and ion transfer across the blood-brain and blood-cerebrospinal fluid barriers; a comparative account of mechanisms and roles. Fluids Barriers CNS. 2016;13(1):19.PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Solár P, Zamani A, Kubíčková L, Dubový P, Joukal M. Choroid plexus and the blood-cerebrospinal fluid barrier in disease. Fluids Barriers CNS. 2020;17(1):35.PubMedPubMedCentralCrossRef Solár P, Zamani A, Kubíčková L, Dubový P, Joukal M. Choroid plexus and the blood-cerebrospinal fluid barrier in disease. Fluids Barriers CNS. 2020;17(1):35.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Hallaert GG, Vanhauwaert DJ, Loggh K, Van Broeck C, Den BE, Van Roost D, et al. Endoscopic coagulation of choroid plexus hyperplasia. J Neurosurg Pediatr. 2012;9(2):169–77.PubMedCrossRef Hallaert GG, Vanhauwaert DJ, Loggh K, Van Broeck C, Den BE, Van Roost D, et al. Endoscopic coagulation of choroid plexus hyperplasia. J Neurosurg Pediatr. 2012;9(2):169–77.PubMedCrossRef
6.
Zurück zum Zitat Karimy JK, Zhang J, Kurland DB, Theriault BC, Duran D, Stokum JA, et al. Inflammation-dependent cerebrospinal fluid hypersecretion by the choroid plexus epithelium in posthemorrhagic hydrocephalus. Nat Med. 2017;23(8):997–1003.PubMedCrossRef Karimy JK, Zhang J, Kurland DB, Theriault BC, Duran D, Stokum JA, et al. Inflammation-dependent cerebrospinal fluid hypersecretion by the choroid plexus epithelium in posthemorrhagic hydrocephalus. Nat Med. 2017;23(8):997–1003.PubMedCrossRef
7.
Zurück zum Zitat Ducros A, Biousse V. Headache arising from idiopathic changes in CSF pressure. Lancet Neurol. 2015;14(6):655–68.PubMedCrossRef Ducros A, Biousse V. Headache arising from idiopathic changes in CSF pressure. Lancet Neurol. 2015;14(6):655–68.PubMedCrossRef
9.
Zurück zum Zitat Kofoed Månsson P, Johansson S, Ziebell M, Juhler M. Forty years of shunt surgery at Rigshospitalet, Denmark: a retrospective study comparing past and present rates and causes of revision and infection. BMJ Open. 2017;7(1): e013389.PubMedPubMedCentralCrossRef Kofoed Månsson P, Johansson S, Ziebell M, Juhler M. Forty years of shunt surgery at Rigshospitalet, Denmark: a retrospective study comparing past and present rates and causes of revision and infection. BMJ Open. 2017;7(1): e013389.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Thurtell MJ, Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management. Curr Treat Options Neurol. 2013;15(1):1–12.PubMedPubMedCentralCrossRef Thurtell MJ, Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management. Curr Treat Options Neurol. 2013;15(1):1–12.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat MacAulay N. Molecular mechanisms of brain water transport. Nat Rev Neurosci. 2021;22(6):326–44.PubMedCrossRef MacAulay N. Molecular mechanisms of brain water transport. Nat Rev Neurosci. 2021;22(6):326–44.PubMedCrossRef
13.
Zurück zum Zitat Abrams ZB, Johnson TS, Huang K, Payne PRO, Coombes K. A protocol to evaluate RNA sequencing normalization methods. BMC Bioinform. 2019;20(Suppl 24):679.CrossRef Abrams ZB, Johnson TS, Huang K, Payne PRO, Coombes K. A protocol to evaluate RNA sequencing normalization methods. BMC Bioinform. 2019;20(Suppl 24):679.CrossRef
14.
Zurück zum Zitat Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15–21.PubMedCrossRef Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15–21.PubMedCrossRef
15.
17.
Zurück zum Zitat Xin J, Mark A, Afrasiabi C, Tsueng G, Juchler M, Gopal N, et al. High-performance web services for querying gene and variant annotation. Genome Biol. 2016;17(1):91.PubMedPubMedCentralCrossRef Xin J, Mark A, Afrasiabi C, Tsueng G, Juchler M, Gopal N, et al. High-performance web services for querying gene and variant annotation. Genome Biol. 2016;17(1):91.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Wu C, Macleod I, Su AI. BioGPS and MyGene.info: organizing online, gene-centric information. Nucleic Acids Res. 2013;41(Database issue):D561–5.PubMedCrossRef Wu C, Macleod I, Su AI. BioGPS and MyGene.info: organizing online, gene-centric information. Nucleic Acids Res. 2013;41(Database issue):D561–5.PubMedCrossRef
19.
Zurück zum Zitat Mi H, Muruganujan A, Ebert D, Huang X, Thomas PD. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 2019;47(D1):D419–26.PubMedCrossRef Mi H, Muruganujan A, Ebert D, Huang X, Thomas PD. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 2019;47(D1):D419–26.PubMedCrossRef
20.
Zurück zum Zitat Carbon S, Ireland A, Mungall CJ, Shu S, Marshall B, Lewis S, et al. AmiGO: online access to ontology and annotation data. Bioinformatics. 2009;25(2):288–9.PubMedCrossRef Carbon S, Ireland A, Mungall CJ, Shu S, Marshall B, Lewis S, et al. AmiGO: online access to ontology and annotation data. Bioinformatics. 2009;25(2):288–9.PubMedCrossRef
21.
Zurück zum Zitat Day-Richter J, Harris MA, Haendel M, Gene Ontology OBO-Edit Working Group, Lewis S. OBO-Edit–an ontology editor for biologists. Bioinformatics. 2007;23(16):2198–200.PubMedCrossRef Day-Richter J, Harris MA, Haendel M, Gene Ontology OBO-Edit Working Group, Lewis S. OBO-Edit–an ontology editor for biologists. Bioinformatics. 2007;23(16):2198–200.PubMedCrossRef
22.
Zurück zum Zitat Rodríguez-Lorenzo S, Ferreira Francisco DM, Vos R, van het Hof B, Rijnsburger M, Schroten H, et al. Altered secretory and neuroprotective function of the choroid plexus in progressive multiple sclerosis. Acta Neuropathol Commun. 2020;8(1):35.PubMedPubMedCentralCrossRef Rodríguez-Lorenzo S, Ferreira Francisco DM, Vos R, van het Hof B, Rijnsburger M, Schroten H, et al. Altered secretory and neuroprotective function of the choroid plexus in progressive multiple sclerosis. Acta Neuropathol Commun. 2020;8(1):35.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207–10.PubMedPubMedCentralCrossRef Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207–10.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res. 2013;41(D1):D991–5.PubMedCrossRef Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res. 2013;41(D1):D991–5.PubMedCrossRef
25.
Zurück zum Zitat Lun MP, Johnson MB, Broadbelt KG, Watanabe M, Kang Y, Chau KF, et al. Spatially heterogeneous choroid plexus transcriptomes encode positional identity and contribute to regional CSF production. J Neurosci. 2015;35(12):4903–16.PubMedPubMedCentralCrossRef Lun MP, Johnson MB, Broadbelt KG, Watanabe M, Kang Y, Chau KF, et al. Spatially heterogeneous choroid plexus transcriptomes encode positional identity and contribute to regional CSF production. J Neurosci. 2015;35(12):4903–16.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Alexander SP, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, et al. the concise guide to pharmacology 2019/20: transporters. Br J Pharmacol. 2019;176(Suppl 1):S397–493.PubMedPubMedCentral Alexander SP, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, et al. the concise guide to pharmacology 2019/20: transporters. Br J Pharmacol. 2019;176(Suppl 1):S397–493.PubMedPubMedCentral
30.
Zurück zum Zitat Alexander SP, Mathie A, Peters JA, Veale EL, Striessnig J, Kelly E, et al. The concise guide to pharmacology 2019/20: Ion channels. Br J Pharmacol. 2019;176(Suppl 1):S142–228.PubMedPubMedCentral Alexander SP, Mathie A, Peters JA, Veale EL, Striessnig J, Kelly E, et al. The concise guide to pharmacology 2019/20: Ion channels. Br J Pharmacol. 2019;176(Suppl 1):S142–228.PubMedPubMedCentral
31.
Zurück zum Zitat Alexander SP, Christopoulos A, Davenport AP, Kelly E, Mathie A, Peters JA, et al. The concise guide to pharmacology 2019/20: G protein-coupled receptors. Br J Pharmacol. 2019;176(Suppl 1):S21–141.PubMedPubMedCentral Alexander SP, Christopoulos A, Davenport AP, Kelly E, Mathie A, Peters JA, et al. The concise guide to pharmacology 2019/20: G protein-coupled receptors. Br J Pharmacol. 2019;176(Suppl 1):S21–141.PubMedPubMedCentral
32.
Zurück zum Zitat HGNC Database, HUGO Gene Nomenclature Committee (HGNC), European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD UK. www.genenames.org. Accessed 15 Nov 2021. HGNC Database, HUGO Gene Nomenclature Committee (HGNC), European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD UK. www.​genenames.​org. Accessed 15 Nov 2021.
36.
Zurück zum Zitat Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 2021;49(D1):D545–51.PubMedCrossRef Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 2021;49(D1):D545–51.PubMedCrossRef
38.
Zurück zum Zitat Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–13.PubMedCrossRef Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–13.PubMedCrossRef
39.
Zurück zum Zitat Otasek D, Morris JH, Bouças J, Pico AR, Demchak B. Cytoscape automation: empowering workflow-based network analysis. Genome Biol. 2019;20(1):185.PubMedPubMedCentralCrossRef Otasek D, Morris JH, Bouças J, Pico AR, Demchak B. Cytoscape automation: empowering workflow-based network analysis. Genome Biol. 2019;20(1):185.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Oernbo EK, Steffensen AB, Khamesi PR, Toft-Bertelsen TL, Barbuskaite D, Vilhardt F, et al. Cerebrospinal fluid formation is controlled by membrane transporters to modulate intracranial pressure. bioRxiv 2021.12.10.472067. Oernbo EK, Steffensen AB, Khamesi PR, Toft-Bertelsen TL, Barbuskaite D, Vilhardt F, et al. Cerebrospinal fluid formation is controlled by membrane transporters to modulate intracranial pressure. bioRxiv 2021.12.10.472067.
43.
Zurück zum Zitat Dani N, Herbst RH, McCabe C, Green GS, Kaiser K, Head JP, et al. A cellular and spatial map of the choroid plexus across brain ventricles and ages. Cell. 2021;184(11):3056-3074.e21.PubMedPubMedCentralCrossRef Dani N, Herbst RH, McCabe C, Green GS, Kaiser K, Head JP, et al. A cellular and spatial map of the choroid plexus across brain ventricles and ages. Cell. 2021;184(11):3056-3074.e21.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595(7868):565–71.PubMedPubMedCentralCrossRef Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595(7868):565–71.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Sathyanesan M, Girgenti MJ, Banasr M, Stone K, Bruce C, Guilchicek E, et al. A molecular characterization of the choroid plexus and stress-induced gene regulation. Transl Psychiatry. 2012;2(7): e139.PubMedPubMedCentralCrossRef Sathyanesan M, Girgenti MJ, Banasr M, Stone K, Bruce C, Guilchicek E, et al. A molecular characterization of the choroid plexus and stress-induced gene regulation. Transl Psychiatry. 2012;2(7): e139.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Kant S, Stopa EG, Johanson CE, Baird A, Silverberg GD. Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer’s disease. Fluids Barriers CNS. 2018;15(1):34.PubMedPubMedCentralCrossRef Kant S, Stopa EG, Johanson CE, Baird A, Silverberg GD. Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer’s disease. Fluids Barriers CNS. 2018;15(1):34.PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Stopa EG, Tanis KQ, Miller MC, Nikonova EV, Podtelezhnikov AA, Finney EM, et al. Comparative transcriptomics of choroid plexus in Alzheimer’s disease, frontotemporal dementia and Huntington’s disease: implications for CSF homeostasis. Fluids Barriers CNS. 2018;15(1):18.PubMedPubMedCentralCrossRef Stopa EG, Tanis KQ, Miller MC, Nikonova EV, Podtelezhnikov AA, Finney EM, et al. Comparative transcriptomics of choroid plexus in Alzheimer’s disease, frontotemporal dementia and Huntington’s disease: implications for CSF homeostasis. Fluids Barriers CNS. 2018;15(1):18.PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Kratzer I, Liddelow SA, Saunders NR, Dziegielewska KM, Strazielle N, Ghersi-Egea JF. Developmental changes in the transcriptome of the rat choroid plexus in relation to neuroprotection. Fluids Barriers CNS. 2013;10(1):25.PubMedPubMedCentralCrossRef Kratzer I, Liddelow SA, Saunders NR, Dziegielewska KM, Strazielle N, Ghersi-Egea JF. Developmental changes in the transcriptome of the rat choroid plexus in relation to neuroprotection. Fluids Barriers CNS. 2013;10(1):25.PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat Ek CJ, Nathanielsz P, Li C, Mallard C. Transcriptomal changes and functional annotation of the developing non-human primate choroid plexus. Front Neurosci. 2015;9:82.PubMedPubMedCentralCrossRef Ek CJ, Nathanielsz P, Li C, Mallard C. Transcriptomal changes and functional annotation of the developing non-human primate choroid plexus. Front Neurosci. 2015;9:82.PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Steffensen AB, Oernbo EK, Stoica A, Gerkau NJ, Barbuskaite D, Tritsaris K, et al. Cotransporter-mediated water transport underlying cerebrospinal fluid formation. Nat Commun. 2018;9(1):2167.PubMedPubMedCentralCrossRef Steffensen AB, Oernbo EK, Stoica A, Gerkau NJ, Barbuskaite D, Tritsaris K, et al. Cotransporter-mediated water transport underlying cerebrospinal fluid formation. Nat Commun. 2018;9(1):2167.PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Plotkin MD, Kaplan MR, Peterson LN, Gullans SR, Hebert SC, Delpire E. Expression of the Na(+)-K(+)-2Cl- cotransporter BSC2 in the nervous system. Am J Physiol. 1997;272(1 Pt 1):C173–83.PubMedCrossRef Plotkin MD, Kaplan MR, Peterson LN, Gullans SR, Hebert SC, Delpire E. Expression of the Na(+)-K(+)-2Cl- cotransporter BSC2 in the nervous system. Am J Physiol. 1997;272(1 Pt 1):C173–83.PubMedCrossRef
52.
Zurück zum Zitat Praetorius J, Nielsen S. Distribution of sodium transporters and aquaporin-1 in the human choroid plexus. Am J Physiol Cell Physiol. 2006;291(1):C59-67.PubMedCrossRef Praetorius J, Nielsen S. Distribution of sodium transporters and aquaporin-1 in the human choroid plexus. Am J Physiol Cell Physiol. 2006;291(1):C59-67.PubMedCrossRef
53.
Zurück zum Zitat Speake T, Freeman LJ, Brown PD. Expression of aquaporin 1 and aquaporin 4 water channels in rat choroid plexus. Biochim Biophys Acta. 2003;1609(1):80–6.PubMedCrossRef Speake T, Freeman LJ, Brown PD. Expression of aquaporin 1 and aquaporin 4 water channels in rat choroid plexus. Biochim Biophys Acta. 2003;1609(1):80–6.PubMedCrossRef
56.
Zurück zum Zitat Perland E, Fredriksson R. Classification systems of secondary active transporters. Trends Pharmacol Sci. 2017;38(3):305–15.PubMedCrossRef Perland E, Fredriksson R. Classification systems of secondary active transporters. Trends Pharmacol Sci. 2017;38(3):305–15.PubMedCrossRef
58.
Zurück zum Zitat Hediger MA, Clémençon B, Burrier RE, Bruford EA. The ABCs of membrane transporters in health and disease (SLC series): introduction. Mol Aspects Med. 2013;34(2–3):95–107.PubMedPubMedCentralCrossRef Hediger MA, Clémençon B, Burrier RE, Bruford EA. The ABCs of membrane transporters in health and disease (SLC series): introduction. Mol Aspects Med. 2013;34(2–3):95–107.PubMedPubMedCentralCrossRef
59.
Zurück zum Zitat Yosten GL, Kolar GR, Redlinger LJ, Samson WK. Evidence for an interaction between proinsulin C-peptide and GPR146. J Endocrinol. 2013;218(2):B1-8.PubMedCrossRef Yosten GL, Kolar GR, Redlinger LJ, Samson WK. Evidence for an interaction between proinsulin C-peptide and GPR146. J Endocrinol. 2013;218(2):B1-8.PubMedCrossRef
60.
Zurück zum Zitat Hills CE, Brunskill NJ. Intracellular signalling by C-peptide. Exp Diabetes Res. 2008;2018:635158. Hills CE, Brunskill NJ. Intracellular signalling by C-peptide. Exp Diabetes Res. 2008;2018:635158.
61.
Zurück zum Zitat Deng QS, Johanson CE. Cyclic AMP alteration of chloride transport into the choroid plexus-cerebrospinal fluid system. Neurosci Lett. 1992;143(1–2):146–50.PubMedCrossRef Deng QS, Johanson CE. Cyclic AMP alteration of chloride transport into the choroid plexus-cerebrospinal fluid system. Neurosci Lett. 1992;143(1–2):146–50.PubMedCrossRef
62.
Zurück zum Zitat Nilsson C, Lindvall-Axelsson M, Owman C. Neuroendocrine regulatory mechanisms in the choroid plexus-cerebrospinal fluid system. Brain Res Brain Res Rev. 1992;17(2):109–38.PubMedCrossRef Nilsson C, Lindvall-Axelsson M, Owman C. Neuroendocrine regulatory mechanisms in the choroid plexus-cerebrospinal fluid system. Brain Res Brain Res Rev. 1992;17(2):109–38.PubMedCrossRef
63.
Zurück zum Zitat Rudman D, Hollins BM, Lewis NC, Scott JW. Effects of hormones on 3’, 5’ -cyclic adenosine monophosphate in choroid plexus. Am J Physiol. 1977;232(4):E353–7.PubMed Rudman D, Hollins BM, Lewis NC, Scott JW. Effects of hormones on 3’, 5’ -cyclic adenosine monophosphate in choroid plexus. Am J Physiol. 1977;232(4):E353–7.PubMed
64.
Zurück zum Zitat von Mering C, Jensen LJ, Snel B, Hooper SD, Krupp M, Foglierini M, et al. STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res. 2005;33(Database issue):D433–7.CrossRef von Mering C, Jensen LJ, Snel B, Hooper SD, Krupp M, Foglierini M, et al. STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res. 2005;33(Database issue):D433–7.CrossRef
65.
Zurück zum Zitat Zhang J, Bhuiyan M, Zhang T, Karimy J, Wu Z, Fiesler V, et al. Modulation of brain cation-Cl- cotransport via the SPAK kinase inhibitor ZT-1a. Nat Commun. 2020;11(1):78.PubMedPubMedCentralCrossRef Zhang J, Bhuiyan M, Zhang T, Karimy J, Wu Z, Fiesler V, et al. Modulation of brain cation-Cl- cotransport via the SPAK kinase inhibitor ZT-1a. Nat Commun. 2020;11(1):78.PubMedPubMedCentralCrossRef
66.
Zurück zum Zitat Toft-Bertelsen TL, Barbuskaite D, Heerfordt EK, Lolansen SD, Andreassen SN, Rostgaard N, et al. Lysophosphatidic acid, a CSF marker in posthemorrhagic hydrocephalus that drives CSF accumulation via TRPV4-induced hyperactivation of NKCC1. bioRxiv 2022.01.24.477507. Toft-Bertelsen TL, Barbuskaite D, Heerfordt EK, Lolansen SD, Andreassen SN, Rostgaard N, et al. Lysophosphatidic acid, a CSF marker in posthemorrhagic hydrocephalus that drives CSF accumulation via TRPV4-induced hyperactivation of NKCC1. bioRxiv 2022.01.24.477507.
67.
Zurück zum Zitat Hochstetler AE, Smith HM, Preston DC, Reed MM, Territo PR, Shim JW, et al. TRPV4 antagonists ameliorate ventriculomegaly in a rat model of hydrocephalus. JCI Insight. 2020;5(18): e137646.PubMedCentralCrossRef Hochstetler AE, Smith HM, Preston DC, Reed MM, Territo PR, Shim JW, et al. TRPV4 antagonists ameliorate ventriculomegaly in a rat model of hydrocephalus. JCI Insight. 2020;5(18): e137646.PubMedCentralCrossRef
69.
Zurück zum Zitat Bennett KM, Liu J, Hoelting C, Stoll J. Expression and analysis of two novel rat organic cation transporter homologs, SLC22A17 and SLC22A23. Mol Cell Biochem. 2011;352(1–2):143–54.PubMedPubMedCentralCrossRef Bennett KM, Liu J, Hoelting C, Stoll J. Expression and analysis of two novel rat organic cation transporter homologs, SLC22A17 and SLC22A23. Mol Cell Biochem. 2011;352(1–2):143–54.PubMedPubMedCentralCrossRef
70.
Zurück zum Zitat Lang M, Salinin S, Ridder D, Kleesiek J, Hroudova J, Berger S, et al. A transgenic approach to identify thyroxine transporter-expressing structures in brain development. J Neuroendocrinol. 2011;23(12):1194–203.PubMedCrossRef Lang M, Salinin S, Ridder D, Kleesiek J, Hroudova J, Berger S, et al. A transgenic approach to identify thyroxine transporter-expressing structures in brain development. J Neuroendocrinol. 2011;23(12):1194–203.PubMedCrossRef
72.
Zurück zum Zitat Matsumoto N, Kitayama H, Kitada M, Kimura K, Noda M, Ide C. Isolation of a set of genes expressed in the choroid plexus of the mouse using suppression subtractive hybridization. Neuroscience. 2003;117(2):405–15.PubMedCrossRef Matsumoto N, Kitayama H, Kitada M, Kimura K, Noda M, Ide C. Isolation of a set of genes expressed in the choroid plexus of the mouse using suppression subtractive hybridization. Neuroscience. 2003;117(2):405–15.PubMedCrossRef
73.
Zurück zum Zitat Bernal J, Guadaño-Ferraz A, Morte B. Thyroid hormone transporters–functions and clinical implications. Nat Rev Endocrinol. 2015;11(7):406–17.PubMedCrossRef Bernal J, Guadaño-Ferraz A, Morte B. Thyroid hormone transporters–functions and clinical implications. Nat Rev Endocrinol. 2015;11(7):406–17.PubMedCrossRef
74.
Zurück zum Zitat Dolgodilina E, Camargo SM, Roth E, Herzog B, Nunes V, Palacín M, et al. Choroid plexus LAT2 and SNAT3 as partners in CSF amino acid homeostasis maintenance. Fluids Barriers CNS. 2020;17(1):17.PubMedPubMedCentralCrossRef Dolgodilina E, Camargo SM, Roth E, Herzog B, Nunes V, Palacín M, et al. Choroid plexus LAT2 and SNAT3 as partners in CSF amino acid homeostasis maintenance. Fluids Barriers CNS. 2020;17(1):17.PubMedPubMedCentralCrossRef
75.
Zurück zum Zitat Nilsson LM, Castresana-Aguirre M, Scott L, Brismar H. RNA-seq reveals altered gene expression levels in proximal tubular cell cultures compared to renal cortex but not during early glucotoxicity. Sci Rep. 2020;10(1):10390.PubMedPubMedCentralCrossRef Nilsson LM, Castresana-Aguirre M, Scott L, Brismar H. RNA-seq reveals altered gene expression levels in proximal tubular cell cultures compared to renal cortex but not during early glucotoxicity. Sci Rep. 2020;10(1):10390.PubMedPubMedCentralCrossRef
76.
Zurück zum Zitat Lee JW, Chou CL, Knepper MA. Deep sequencing in microdissected renal tubules identifies nephron segment-specific transcriptomes. J Am Soc Nephrol. 2015;26(11):2669–77.PubMedPubMedCentralCrossRef Lee JW, Chou CL, Knepper MA. Deep sequencing in microdissected renal tubules identifies nephron segment-specific transcriptomes. J Am Soc Nephrol. 2015;26(11):2669–77.PubMedPubMedCentralCrossRef
77.
Zurück zum Zitat Oshio K, Watanabe H, Song Y, Verkman AS, Manley GT. Reduced cerebrospinal fluid production and intracranial pressure in mice lacking choroid plexus water channel Aquaporin-1. FASEB J. 2005;19(1):76–8.PubMedCrossRef Oshio K, Watanabe H, Song Y, Verkman AS, Manley GT. Reduced cerebrospinal fluid production and intracranial pressure in mice lacking choroid plexus water channel Aquaporin-1. FASEB J. 2005;19(1):76–8.PubMedCrossRef
78.
Zurück zum Zitat Pollay M, Hisey B, Reynolds E, Tomkins P, Stevens FA, Smith R. Choroid plexus Na+/K+-activated adenosine triphosphatase and cerebrospinal fluid formation. Neurosurgery. 1985;17(5):768–72.PubMedCrossRef Pollay M, Hisey B, Reynolds E, Tomkins P, Stevens FA, Smith R. Choroid plexus Na+/K+-activated adenosine triphosphatase and cerebrospinal fluid formation. Neurosurgery. 1985;17(5):768–72.PubMedCrossRef
80.
Zurück zum Zitat Numata T, Sato-Numata K, Hermosura MC, Mori Y, Okada Y. TRPM7 is an essential regulator for volume-sensitive outwardly rectifying anion channel. Commun Biol. 2021;4(1):599.PubMedPubMedCentralCrossRef Numata T, Sato-Numata K, Hermosura MC, Mori Y, Okada Y. TRPM7 is an essential regulator for volume-sensitive outwardly rectifying anion channel. Commun Biol. 2021;4(1):599.PubMedPubMedCentralCrossRef
81.
Zurück zum Zitat Vrhovac I, Balen Eror D, Klessen D, Burger C, Breljak D, Kraus O, et al. Localizations of Na(+)-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart. Pflugers Arch. 2015;467(9):1881–98.PubMedCrossRef Vrhovac I, Balen Eror D, Klessen D, Burger C, Breljak D, Kraus O, et al. Localizations of Na(+)-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart. Pflugers Arch. 2015;467(9):1881–98.PubMedCrossRef
82.
Zurück zum Zitat Chiba Y, Sugiyama Y, Nishi N, Nonaka W, Murakami R, Ueno M. Sodium/glucose cotransporter 2 is expressed in choroid plexus epithelial cells and ependymal cells in human and mouse brains. Neuropathology. 2020;40(5):482–91.PubMedPubMedCentralCrossRef Chiba Y, Sugiyama Y, Nishi N, Nonaka W, Murakami R, Ueno M. Sodium/glucose cotransporter 2 is expressed in choroid plexus epithelial cells and ependymal cells in human and mouse brains. Neuropathology. 2020;40(5):482–91.PubMedPubMedCentralCrossRef
83.
Zurück zum Zitat Chiba Y, Murakami R, Matsumoto K, Wakamatsu K, Nonaka W, Uemura N, et al. Glucose, fructose, and urate transporters in the choroid plexus epithelium. Int J Mol Sci. 2020;21(19):7230.PubMedCentralCrossRef Chiba Y, Murakami R, Matsumoto K, Wakamatsu K, Nonaka W, Uemura N, et al. Glucose, fructose, and urate transporters in the choroid plexus epithelium. Int J Mol Sci. 2020;21(19):7230.PubMedCentralCrossRef
84.
Zurück zum Zitat Wright, EM, Sala-Rabanal, M, Ghezzi, C & Loo, DDF 2018, Sugar Absorption. Physiology of the Gastrointestinal Tract: Sixth Edition. Vol. 2–2, Elsevier Inc., pp. 1051–1062. Wright, EM, Sala-Rabanal, M, Ghezzi, C & Loo, DDF 2018, Sugar Absorption. Physiology of the Gastrointestinal Tract: Sixth Edition. Vol. 2–2, Elsevier Inc., pp. 1051–1062.
87.
Zurück zum Zitat Saunders NR, Dziegielewska KM, Møllgård K, Habgood MD, Wakefield MJ, Lindsay H, et al. Influx mechanisms in the embryonic and adult rat choroid plexus: a transcriptome study. Front Neurosci. 2015;9:123.PubMedPubMedCentralCrossRef Saunders NR, Dziegielewska KM, Møllgård K, Habgood MD, Wakefield MJ, Lindsay H, et al. Influx mechanisms in the embryonic and adult rat choroid plexus: a transcriptome study. Front Neurosci. 2015;9:123.PubMedPubMedCentralCrossRef
89.
Zurück zum Zitat Rouault TA, Zhang DL, Jeong SY. Brain iron homeostasis, the choroid plexus, and localization of iron transport proteins. Metab Brain Dis. 2009;24(4):673–84.PubMedPubMedCentralCrossRef Rouault TA, Zhang DL, Jeong SY. Brain iron homeostasis, the choroid plexus, and localization of iron transport proteins. Metab Brain Dis. 2009;24(4):673–84.PubMedPubMedCentralCrossRef
90.
Zurück zum Zitat Marger L, Schubert CR, Bertrand D. Zinc: an underappreciated modulatory factor of brain function. Biochem Pharmacol. 2014;91(4):426–35.PubMedCrossRef Marger L, Schubert CR, Bertrand D. Zinc: an underappreciated modulatory factor of brain function. Biochem Pharmacol. 2014;91(4):426–35.PubMedCrossRef
91.
Zurück zum Zitat Herrick-Davis K, Grinde E, Lindsley T, Teitler M, Mancia F, Cowan A, et al. Native serotonin 5-HT2C receptors are expressed as homodimers on the apical surface of choroid plexus epithelial cells. Mol Pharmacol. 2015;87(4):660–73.PubMedPubMedCentralCrossRef Herrick-Davis K, Grinde E, Lindsley T, Teitler M, Mancia F, Cowan A, et al. Native serotonin 5-HT2C receptors are expressed as homodimers on the apical surface of choroid plexus epithelial cells. Mol Pharmacol. 2015;87(4):660–73.PubMedPubMedCentralCrossRef
92.
Zurück zum Zitat Shipley F, Dani N, Xu H, Deister C, Cui J, Head J, et al. Tracking calcium dynamics and immune surveillance at the choroid plexus blood-cerebrospinal fluid interface. Neuron. 2020;108(4):623-639.e10.PubMedPubMedCentralCrossRef Shipley F, Dani N, Xu H, Deister C, Cui J, Head J, et al. Tracking calcium dynamics and immune surveillance at the choroid plexus blood-cerebrospinal fluid interface. Neuron. 2020;108(4):623-639.e10.PubMedPubMedCentralCrossRef
93.
Zurück zum Zitat Mazucanti C, Liu Q, Lang D, Huang N, O’Connell J, Camandola S, et al. Release of insulin produced by the choroid plexis is regulated by serotonergic signaling. JCI Insight. 2019;4(23): e131682.PubMedCentralCrossRef Mazucanti C, Liu Q, Lang D, Huang N, O’Connell J, Camandola S, et al. Release of insulin produced by the choroid plexis is regulated by serotonergic signaling. JCI Insight. 2019;4(23): e131682.PubMedCentralCrossRef
94.
Zurück zum Zitat Speake T, Kibble JD, Brown PD. Kv1.1 and Kv1.3 channels contribute to the delayed-rectifying K+ conductance in rat choroid plexus epithelial cells. Am J Physiol Cell Physiol. 2004;286(3):C611–20.PubMedCrossRef Speake T, Kibble JD, Brown PD. Kv1.1 and Kv1.3 channels contribute to the delayed-rectifying K+ conductance in rat choroid plexus epithelial cells. Am J Physiol Cell Physiol. 2004;286(3):C611–20.PubMedCrossRef
95.
Zurück zum Zitat Lindvall-Axelsson M, Mathew C, Nilsson C, Owman C. Effect of 5-hydroxytryptamine on the rate of cerebrospinal fluid production in rabbit. Exp Neurol. 1988;99(2):362–8.PubMedCrossRef Lindvall-Axelsson M, Mathew C, Nilsson C, Owman C. Effect of 5-hydroxytryptamine on the rate of cerebrospinal fluid production in rabbit. Exp Neurol. 1988;99(2):362–8.PubMedCrossRef
96.
Zurück zum Zitat Fisone G, Snyder GL, Fryckstedt J, Caplan MJ, Aperia A, Greengard P. Na+, K(+)-ATPase in the choroid plexus. Regulation by serotonin/protein kinase C pathway. J Biol Chem. 1995;270(6):2427–30.PubMed Fisone G, Snyder GL, Fryckstedt J, Caplan MJ, Aperia A, Greengard P. Na+, K(+)-ATPase in the choroid plexus. Regulation by serotonin/protein kinase C pathway. J Biol Chem. 1995;270(6):2427–30.PubMed
97.
Zurück zum Zitat Angelova K, Puett D, Narayan P. Identification of endothelin receptor subtypes in sheep choroid plexus. Endocrine. 1997;7(3):287–93.PubMedCrossRef Angelova K, Puett D, Narayan P. Identification of endothelin receptor subtypes in sheep choroid plexus. Endocrine. 1997;7(3):287–93.PubMedCrossRef
98.
Zurück zum Zitat Schalk KA, Faraci FM, Heistad DD. Effect of endothelin on production of cerebrospinal fluid in rabbits. Stroke. 1992;23(4):560–3.PubMedCrossRef Schalk KA, Faraci FM, Heistad DD. Effect of endothelin on production of cerebrospinal fluid in rabbits. Stroke. 1992;23(4):560–3.PubMedCrossRef
99.
Zurück zum Zitat Kadel KA, Heistad DD, Faraci FM. Effects of endothelin on blood vessels of the brain and choroid plexus. Brain Res. 1990;518(1–2):78–82.PubMedCrossRef Kadel KA, Heistad DD, Faraci FM. Effects of endothelin on blood vessels of the brain and choroid plexus. Brain Res. 1990;518(1–2):78–82.PubMedCrossRef
100.
Zurück zum Zitat Szmydynger-Chodobska J, Chun ZG, Johanson CE, Chodobski A. Distribution of fibroblast growth factor receptors and their co-localization with vasopressin in the choroid plexus epithelium. NeuroReport. 2002;13(2):257–9.PubMedCrossRef Szmydynger-Chodobska J, Chun ZG, Johanson CE, Chodobski A. Distribution of fibroblast growth factor receptors and their co-localization with vasopressin in the choroid plexus epithelium. NeuroReport. 2002;13(2):257–9.PubMedCrossRef
101.
Zurück zum Zitat Panet R, Atlan H. Stimulation of bumetanide-sensitive Na+/K+/Cl- cotransport by different mitogens in synchronized human skin fibroblasts is essential for cell proliferation. J Cell Biol. 1991;114(2):337–42.PubMedCrossRef Panet R, Atlan H. Stimulation of bumetanide-sensitive Na+/K+/Cl- cotransport by different mitogens in synchronized human skin fibroblasts is essential for cell proliferation. J Cell Biol. 1991;114(2):337–42.PubMedCrossRef
102.
Zurück zum Zitat Johanson CE, Szmydynger-Chodobska J, Chodobski A, Baird A, McMillan P, Stopa EG. Altered formation and bulk absorption of cerebrospinal fluid in FGF-2-induced hydrocephalus. Am J Physiol. 1999;277(1):R263–71.PubMed Johanson CE, Szmydynger-Chodobska J, Chodobski A, Baird A, McMillan P, Stopa EG. Altered formation and bulk absorption of cerebrospinal fluid in FGF-2-induced hydrocephalus. Am J Physiol. 1999;277(1):R263–71.PubMed
103.
Zurück zum Zitat Coll G, Arnaud E, Collet C, Brunelle F, Sainte-Rose C, Di Rocco F. Skull base morphology in fibroblast growth factor receptor type 2-related faciocraniosynostosis: a descriptive analysis. Neurosurgery. 2015;76(5):571–83.PubMedCrossRef Coll G, Arnaud E, Collet C, Brunelle F, Sainte-Rose C, Di Rocco F. Skull base morphology in fibroblast growth factor receptor type 2-related faciocraniosynostosis: a descriptive analysis. Neurosurgery. 2015;76(5):571–83.PubMedCrossRef
104.
Zurück zum Zitat Johanson CE, Donahue JE, Spangenberger A, Stopa EG, Duncan JA, Sharma HS. Atrial natriuretic peptide: its putative role in modulating the choroid plexus-CSF system for intracranial pressure regulation. Acta Neurochir Suppl. 2006;96:451–6.PubMedCrossRef Johanson CE, Donahue JE, Spangenberger A, Stopa EG, Duncan JA, Sharma HS. Atrial natriuretic peptide: its putative role in modulating the choroid plexus-CSF system for intracranial pressure regulation. Acta Neurochir Suppl. 2006;96:451–6.PubMedCrossRef
105.
Zurück zum Zitat Chodobski A, Szmydynger-Chodobska J, Cooper E, McKinley MJ. Atrial natriuretic peptide does not alter cerebrospinal fluid formation in sheep. Am J Physiol. 1992;262(5 Pt 2):R860–4.PubMed Chodobski A, Szmydynger-Chodobska J, Cooper E, McKinley MJ. Atrial natriuretic peptide does not alter cerebrospinal fluid formation in sheep. Am J Physiol. 1992;262(5 Pt 2):R860–4.PubMed
106.
Zurück zum Zitat Mori K, Tsutsumi K, Kurihara M, Kawaguchi T, Niwa M. Alteration of atrial natriuretic peptide receptors in the choroid plexus of rats with induced or congenital hydrocephalus. Childs Nerv Syst. 1990;6(4):190–3.PubMedCrossRef Mori K, Tsutsumi K, Kurihara M, Kawaguchi T, Niwa M. Alteration of atrial natriuretic peptide receptors in the choroid plexus of rats with induced or congenital hydrocephalus. Childs Nerv Syst. 1990;6(4):190–3.PubMedCrossRef
107.
Zurück zum Zitat Speake T, Brown PD. Ion channels in epithelial cells of the choroid plexus isolated from the lateral ventricle of rat brain. Brain Res. 2004;1005(1–2):60–6.PubMedCrossRef Speake T, Brown PD. Ion channels in epithelial cells of the choroid plexus isolated from the lateral ventricle of rat brain. Brain Res. 2004;1005(1–2):60–6.PubMedCrossRef
108.
Zurück zum Zitat Uchida Y, Zhang Z, Tachikawa M, Terasaki T. Quantitative targeted absolute proteomics of rat blood-cerebrospinal fluid barrier transporters: comparison with a human specimen. J Neurochem. 2015;134(6):1104–15.PubMedCrossRef Uchida Y, Zhang Z, Tachikawa M, Terasaki T. Quantitative targeted absolute proteomics of rat blood-cerebrospinal fluid barrier transporters: comparison with a human specimen. J Neurochem. 2015;134(6):1104–15.PubMedCrossRef
Metadaten
Titel
Transcriptional profiling of transport mechanisms and regulatory pathways in rat choroid plexus
verfasst von
Søren N. Andreassen
Trine L. Toft-Bertelsen
Jonathan H. Wardman
René Villadsen
Nanna MacAulay
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
Fluids and Barriers of the CNS / Ausgabe 1/2022
Elektronische ISSN: 2045-8118
DOI
https://doi.org/10.1186/s12987-022-00335-x

Weitere Artikel der Ausgabe 1/2022

Fluids and Barriers of the CNS 1/2022 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

03.05.2024 Parkinson-Krankheit Nachrichten

Kann eine frühzeitige Stuhltransplantation das Fortschreiten von Parkinson-Symptomen verlangsamen? Die Ergebnisse einer randomisierten Phase-2-Studie scheinen dafür zu sprechen.

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

02.05.2024 Hirnblutung Nachrichten

Erhalten Personen mit einer spontanen Hirnblutung innerhalb von zwei Stunden nach Symptombeginn eine Tranexamsäure-Therapie, kann dies weder die Hämatomexpansion eindämmen noch die Mortalität senken.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders scheint das auf weibliche Kranke zuzutreffen, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.